详情页 - 云南省第一人民医院机构库

当前位置：首页 > 详情页

Response to concerns on "Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in China"

18| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ CSCD-C ◇ ESCI ◇ 中华系列

作者：

机构： [1]China Japan Friendship Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China [2]First Peoples Hosp Yinchuan, Dept Otorhinolaryngol Head & Neck Surg, Yinchuan, Peoples R China [3]First People's Hosp Yunnan Prov, Dept Otorhinolaryngol, Kunming, Peoples R China [4]Nanjing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol, Nanjing, Peoples R China [5]Nanjing Med Univ, Affiliated Hosp 1, Clin Allergy Ctr, Nanjing, Peoples R China [6]Chongqing Med Univ, Affiliated Hosp 1, Dept Otorhinolaryngol Head & Neck Surg, Chongqing, Peoples R China

出处：

DOI：

ISSN：

关键词： epidemiology studies incidence olfactory disorders prognosis SARS-CoV-2 taste disorders

语种：

WOS：

PubmedID：

JCR分区：

出版当年[2023]版：

Q2 OTORHINOLARYNGOLOGY

最新[2023]版：

Q2 OTORHINOLARYNGOLOGY

影响因子： 1.9 最新[2023版] 0 最新五年平均 1.9 出版当年[2023版] 0 出版当年五年平均 0 出版前一年[2022版]

第一作者：

第一作者机构： [1]China Japan Friendship Hosp, Dept Otorhinolaryngol Head & Neck Surg, Beijing, Peoples R China

通讯作者：

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Incidence and prognosis of olfactory and gustatory dysfunctions related to SARS-CoV-2 Omicron strain infection in mainland China: A national multicenter survey of 35,566 individuals [2]新型冠状病毒Omicron株感染后嗅觉和味觉障碍的发病率和预后：35 566份中国多中心大规模调查数据分析 [3]A multicentre observational study on neonates exposed to SARS-CoV-2 in China: The Neo-SARS-CoV-2 Study protocol(Open Access) [4]Lung Organoids as Model to Study SARS-CoV-2 Infection [5]Infection with novel coronavirus (SARS-CoV-2) causes pneumonia in Rhesus macaques (Open Access) [6]Chinese Expert Consensus on the Nucleic Acid Detection of SARS-CoV-2. [7]SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity [8]Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients [9]Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV [10]实体器官移植受者新型冠状病毒感染诊疗专家共识（2023年版）